SCHEMBL7656366

SCHEMBL7656366

COC(=O)CS(=O)(=O)c1ccc(C(=O)O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.56
CA12 O43570 4/20 0.56
CA9 Q16790 4/20 0.56
CA1 P00915 3/20 0.56
TSHR P16473 2/20 0.51
HSD17B10 Q99714 1/20 0.51
F2 P00734 1/20 0.50
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
PRSS3 P35030 1/20 0.50
HSD11B1 P28845 2/20 0.49
KMT2A Q03164 1/20 0.49
POLB P06746 2/20 0.48
CA3 P07451 1/20 0.47
CA6 P23280 1/20 0.47
CYP2C19 P33261 1/20 0.47
CA5A P35218 1/20 0.47
CA7 P43166 1/20 0.47
CA14 Q9ULX7 1/20 0.47
CA5B Q9Y2D0 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL602 0.84 HSD11B1 (0.59) HSD17B10HSD11B1KMT2APOLBALDH1A1
SCHEMBL8959069 0.82 HSD11B1 (0.58) HSD17B10HSD11B1KMT2APOLBALDH1A1
SCHEMBL4022229 0.82 ALDH1A1 (0.62) CA2CA12CA9CA1HSD17B10
SCHEMBL14388883 0.81 HSD11B1 (0.53) CA2CA12CA9CA1HSD11B1
SCHEMBL7662115 0.81 F2 (0.55) CA2CA1F2PRSS1PRSS2
SCHEMBL17550651 0.81 GAA (0.53) CA2CA12CA9CA1TSHR
SCHEMBL1346520 0.81 ALDH1A1 (0.65) CA2CA12CA9CA1F2
SCHEMBL1346537 0.81 HTT (0.58) CA2CA1HSD11B1KMT2APOLB
SCHEMBL2069531 0.81 SMN1; SMN2 (0.52) CA2CA12CA9F2PRSS1
SCHEMBL13299623 0.81 PLCG1 (0.52) CA2CA1F2PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6437132-B2 INHIBITOR OF GONADOTROPIN RELEASING HORMONE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-08-20 US disclosed
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-08-15 US disclosed
US-6355633-B1 CONTRACEPTIVES AMERICAN HOME PRODUCTS CORPORATION 2002-03-12 US disclosed
WO-2000058277-A1 ARYL SULFONIC ACIDS AND DERIVATIVES AS FSH ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists FSHR, GNRHR, LHCGR CA2 455/4885CA12 659/4885CA9 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.